Monti E, Paracchini L, Piccinini F, Rozza A, Villani F
Cattedra di Farmacologia Applicata, Università di Milano.
Pharmacol Res Commun. 1988 May;20(5):369-76. doi: 10.1016/s0031-6989(88)80012-2.
The effect of four calcium-modulating agents on myocardial doxorubicin (DXR) accumulation was studied: the calcium-inhibitors verapamil (0.1 microM), trifluoperazine (5 microM) and flunarizine (0.05 microM) and the calcium-mobilizer taurine (50 mM). Myocardial cells of isolated Langendorff rat hearts receiving the drugs showed a significantly enhanced 14C-DXR uptake. These observations are in contrast with the hypothesis that DXR accumulation processes may be related to a decrease in calcium influx and suggest that a combined therapy with DXR and calcium-modulating agents might enhance the drug-induced cardiotoxicity.
研究了四种钙调节剂对心肌阿霉素(DXR)蓄积的影响:钙抑制剂维拉帕米(0.1微摩尔)、三氟拉嗪(5微摩尔)和氟桂利嗪(0.05微摩尔)以及钙动员剂牛磺酸(50毫摩尔)。接受这些药物的离体Langendorff大鼠心脏的心肌细胞显示14C-DXR摄取显著增强。这些观察结果与DXR蓄积过程可能与钙内流减少有关的假设相反,并表明DXR与钙调节剂联合治疗可能会增强药物诱导的心脏毒性。